New research shows the BTK inhibitor ibrutinib accelerates remyelination by reprogramming microglial extracellular vesicles to carry the repair-promoting microRNA miR-223.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.